The Food and Drug Administration’s cleared SeaSpine’s 7D Percutaneous Spine Module for spinal surgery. The company’s shares are higher. SeaSpine (SPNE) shares rose on Thursday as analysts reacted ...
STOCKHOLM, Nov. 8, 2019 /PRNewswire/ -- After a period of assessment of Ortoma's surgical system for hip surgery, the company is now taking the step next step and initiates expansion of Ortoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results